Search

23 Feb 2024: Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients. ... 33: Smith RM, Jones RB, Jayne DR. Progress in treatment of ANCA-associated vasculitis.

23 Feb 2024: Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Ann Rheum Dis. ... Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.

Human antibody approved for treatment of lupus. ... Published on. 11 March, 2011. Systemic lupus erythematosus is a chronic, life-threatening inflammatory autoimmune disease that can cause debilitating fatigue, painful and swollen joints, fever, skin rash

1540: Henry VIII founds the Regius Professorship of Physic, the fourth oldest professorship at Cambridge. ... 2022: Fellow Prof. Rahul Roychoudhuri signs a partnership with AstraZeneca to advance the treatment of lupus.

Yonath (Weizmann Institute of Science, Israel). The trio showed how the information encoded on strands of DNA […]. Human Antibodies developed for Treatment of Lupus and Anthrax. ... treat lupus, a potentially fatal autoimmune disease, and anthrax, a

Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients. ... An audit of recording cardiovascular risk factors in patients with rheumatoid arthritis and systemic lupus erythematosus in

{"id":14777,"date":"2019-07-10T09:30:53","date_gmt":"2019-07-10T08:30:53","guid":{"rendered":"https://www2.mrc-lmb.cam.ac.uk/?p=14777"},"modified":"2019-07-10T09:30:53","modified_gmt":"2019-07-10T08:30:53","slug":"insights-into-how-kap1-silences-vira